4D Molecular Therapeutics, Inc. (FDMT)

Typically moves ±4.28% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-12 APPROXIMATE

4D Molecular Therapeutics, Inc. (FDMT) has a 22-report earnings history dating back to May 13, 2021. Its average absolute post-earnings move is ±4.28%, and 63.6% of those reactions were positive. Its largest post-earnings gain was +12.75% (Nov 09, 2022) and its largest decline was -8.61% (Feb 28, 2025). The next earnings report is predicted for 2026-11-12 (approximate).

Earnings reactions

How FDMT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.28%

Positive %

63.6%

Negative %

36.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 13, 2026	☽ POST	+4.93%	open_in_new
May 07, 2026	☽ POST	+1.86%	open_in_new
Mar 18, 2026	☽ POST	+4.91%	open_in_new
Nov 10, 2025	☀ PRE	-3.14%	open_in_new
Aug 11, 2025	☀ PRE	-1.78%	open_in_new
May 08, 2025	☽ POST	-4.94%	open_in_new
Feb 28, 2025	☽ POST	-8.61%	open_in_new
Nov 13, 2024	☽ POST	+4.02%	open_in_new
Aug 08, 2024	☽ POST	+0.48%	open_in_new
May 09, 2024	☽ POST	+0.23%	open_in_new
Feb 29, 2024	☽ POST	+4.82%	open_in_new
Nov 09, 2023	☽ POST	+5.24%	open_in_new
Aug 09, 2023	☽ POST	-2.29%	open_in_new
May 11, 2023	☽ POST	+5.98%	open_in_new
Mar 15, 2023	☽ POST	+5.7%	open_in_new
Nov 09, 2022	☽ POST	+12.75%	open_in_new
Aug 11, 2022	☽ POST	-8.27%	open_in_new
May 12, 2022	☽ POST	-4.35%	open_in_new
Mar 28, 2022	☽ POST	+6.1%	open_in_new
Nov 10, 2021	☽ POST	+0.2%	open_in_new
Aug 12, 2021	☽ POST	-3.19%	open_in_new
May 13, 2021	☽ POST	+0.3%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.28%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2022 · SEC 13-F

View all 1 →

Funds holding

$53

Total value held

Buying

1 added · 0 reduced

Amalgamated Financial Corp.

$53 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260903	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
144	20260819	open_in_new SEC.gov
144	20260817	open_in_new SEC.gov
4	20260817	open_in_new SEC.gov
10-Q	20260813	open_in_new SEC.gov
144	20260813	open_in_new SEC.gov
8-K	20260813	open_in_new SEC.gov
4	20260805	open_in_new SEC.gov
144	20260804	open_in_new SEC.gov

Frequently asked about FDMT earnings

When does 4D Molecular Therapeutics, Inc. report earnings next? expand_more

4D Molecular Therapeutics, Inc. (FDMT)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does FDMT stock move after earnings? expand_more

Over 22 reports, FDMT has moved an average of ±4.28% the session after earnings, closing higher 63.6% of the time.

What was FDMT's biggest post-earnings move? expand_more

FDMT's largest post-earnings gain on record was +12.75% on Nov 09, 2022, and its largest decline was -8.61% on Feb 28, 2025.

Where can I find 4D Molecular Therapeutics, Inc.'s SEC filings? expand_more

All of 4D Molecular Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.